FDA Inspection 1284308 — Abryl Laboratories Private Limited

Abryl Laboratories Private Limited — FEI 3015793804

The FDA completed an inspection of Abryl Laboratories Private Limited on Sep 26, 2025 in Dera Bassi SAS Nagar. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Sep 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dera Bassi SAS Nagar (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.